Anatomic Pathology Market Growth - Market Analysis, Size, Share, Trends, Demand, Overview and Segment Forecast To 2030

The global anatomic pathology market is projected to grow at a CAGR of nearly 8% during the forecast period. Market expansion is primarily driven by the growing incidence of cancer and chronic diseases, the rising adoption of personalized medicine, the increasing focus on early diagnosis and prevention, and the broadening applications of anatomic pathology in oncology, gastroenterology, and gynecology. However, the lack of skilled pathologists and the high costs associated with advanced pathology instruments and maintenance may limit growth to some extent.

Get Free Sample Report: https://meditechinsights.com/anatomic-pathology-market/request-sample/

Anatomic pathology is a specialized field of medical science focused on examining the structural and morphological characteristics of tissues and organs to identify the cause and nature of diseases. It plays a crucial role in diagnosing various conditions by analyzing tissue samples obtained from biopsies, surgical resections, or autopsies. This branch of pathology provides essential information to physicians, helping them determine disease progression and design targeted treatment plans. Its role is especially critical in areas such as oncology, where precise tissue analysis guides therapeutic decisions, as well as in gastroenterology and gynecology for managing complex disorders.

The market is undergoing a major transformation with the growing integration of personalized medicine and artificial intelligence (AI). Personalized medicine, which customizes treatment based on an individual’s genetic makeup, is becoming a key growth driver in anatomic pathology. By aligning therapy selection with a patient’s unique molecular profile, it enhances treatment accuracy and minimizes side effects. For instance, targeted anticancer therapies based on pharmacogenomic testing are improving clinical outcomes in oncology and are gradually being adopted in cardiovascular and autoimmune diseases as well. Furthermore, the use of AI and machine learning in pathology is facilitating genomic profiling and biomarker discovery. These technologies enhance efficiency, scalability, and diagnostic accuracy, paving the way for more effective and individualized treatment approaches.

The rising demand for companion diagnostics (CDx) is another key factor fueling market growth. Anatomic pathology forms the foundation of companion diagnostics by providing detailed insights into tissue morphology, molecular alterations, and biomarker expression. Techniques such as immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), and next-generation sequencing (NGS) play a crucial role in identifying genetic mutations and protein markers that determine patient eligibility for targeted therapies. These diagnostics enable physicians to personalize treatment, reduce adverse reactions, and improve therapeutic outcomes while optimizing healthcare costs.

Recent developments in the anatomic pathology market reflect the growing focus on precision diagnostics and innovation. In May 2025, NeoGenomics Inc. launched the c-MET CDx for non-small cell lung cancer (NSCLC), a rapid companion diagnostic assay detecting c-Met protein overexpression within 48 hours. In April 2025, Labcorp introduced two liquid biopsy solutions — Labcorp Plasma Detect, a whole-genome sequencing test for molecular residual disease detection in stage III colon cancer, and PGDx elio plasma focus Dx, the first FDA-authorized pan-solid tumor liquid biopsy kit for therapy selection from blood samples. Similarly, in July 2024, Danaher Corporation announced the launch of two CLIA- and CAP-certified laboratories to accelerate the development of companion and complementary diagnostics.

The competitive landscape of the anatomic pathology market includes several global leaders and emerging players such as F. Hoffmann-La Roche Ltd., Danaher Corporation, Agilent Technologies, Merck KGaA, Cardinal Health Inc., PHC Holdings Corp., PerkinElmer Inc., Becton, Dickinson and Company, Laboratory Corporation of America (Labcorp), and NeoGenomics Laboratories Inc. Key strategies adopted by these companies include continuous innovation in diagnostic technologies like multiplex biomarker assays and precision staining systems, mergers and acquisitions to strengthen portfolios, and strategic investments in R&D to streamline pathology workflows and advance personalized healthcare solutions.

Key Market Drivers

• Increasing incidence of cancer and chronic disorders
• Rising adoption of personalized medicine
• Expanding applications in oncology, gastroenterology, and gynecology
• Greater emphasis on early disease detection and prevention
• Rapid advancements in digital pathology and AI-driven diagnostics

Attractive Market Opportunities

• Growing demand for companion diagnostics in oncology
• Rising investments in digital and telepathology platforms
• Increasing collaborations among diagnostic labs, pharmaceutical firms, and AI companies
• Supportive government initiatives and funding for advanced pathology infrastructure

Global Anatomic Pathology Market Segmentation

According to Medi-Tech Insights, the global anatomic pathology market has been analyzed at both regional and country levels from 2023 to 2030. The report further segments the market by product and services, application, and end-user, providing comprehensive insights into evolving trends, key growth areas, and emerging opportunities across the global landscape.

Market Size & Forecast (2023-2030), By Products & Services, USD Million

•  
• Instruments
• Microtomes & Cryostat
• Tissue Processors
• Automatic Stainers
• Whole Slide Imaging Scanners (WSI)
• Other Products
• Consumables
• Reagents & Antibodies
• Probes & Kits
• Others
• Services

Market Size & Forecast (2023-2030), By Application, USD Million

•  
• Disease Diagnosis
• Drug Discovery and Development
• Others

Market Size & Forecast (2023-2030), By End-user, USD Million

•  
• Hospitals
• Research Laboratories
• Diagnostic Laboratories
• Others

 Browse Report: https://meditechinsights.com/anatomic-pathology-market/

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde

Associate, Medi-Tech Insights

+32 498 86 80 79

info@meditechinsights.com